Article Details

Foghorn Therapeutics Provides Update on Phase 1 Study of FHD-286 in Relapsed and/or ...

Retrieved on: 2022-05-21 15:51:11

Tags for this article:

Click the tags to see associated articles and topics

Foghorn Therapeutics Provides Update on Phase 1 Study of FHD-286 in Relapsed and/or .... View article details on hiswai:

Excerpt

The Company is developing multiple product candidates in oncology. ... PipelineReview.com is powered by La Merie Business Intelligence La Merie ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up